ITEOS THERAPEUTICS INC (ITOS) Forecast, Price Target & Analyst Ratings

NASDAQ:ITOSUS46565G1040

Current stock price

10.15 USD
+0.02 (+0.2%)
At close:
10.17 USD
+0.02 (+0.2%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ITEOS THERAPEUTICS INC (ITOS).

Forecast Snapshot

Consensus Price Target

Price Target
$10.56
+ 4.00% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 10, 2025
Period
Q3 / 2025
EPS Estimate
-$1.18
Revenue Estimate

ChartMill Buy Consensus

Rating
50.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.56
Upside
+ 4.00%
From current price of $10.15 to mean target of $10.56, Based on 10 analyst forecasts
Low
$10.10
Median
$10.25
High
$11.55

Price Target Revisions

1 Month
-11.92%
3 Months
-11.92%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for ITOS. The average price target is 10.56 USD. This implies a price increase of 4% is expected in the next year compared to the current price of 10.15.
The average price target has been revised downward by 11.92% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ITOS Current Analyst RatingITOS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ITOS Historical Analyst RatingsITOS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
50.00%
ITOS was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about ITOS.
In the previous month the buy percentage consensus was at a similar level.
ITOS was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-07Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-05-28WedbushDowngrade Outperform -> Neutral
2025-05-28Wells FargoDowngrade Overweight -> Equal-Weight
2025-05-14Leerink PartnersDowngrade Outperform -> Market Perform
2025-05-14Wells FargoMaintains Overweight -> Overweight
2025-05-14Piper SandlerMaintains Overweight -> Overweight
2025-05-14HC Wainwright & Co.Downgrade Buy -> Neutral
2025-05-13JP MorganDowngrade Overweight -> Neutral
2025-04-29Wells FargoMaintains Overweight -> Overweight
2025-03-06Wells FargoMaintains Overweight -> Overweight
2025-03-06JP MorganMaintains Overweight -> Overweight
2025-03-06HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-19Wells FargoMaintains Overweight -> Overweight
2024-12-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-13Wells FargoInitiate Overweight
2024-08-12JP MorganMaintains Overweight -> Overweight
2024-05-13HC Wainwright & Co.Maintains Buy -> Buy
2024-03-12JP MorganMaintains Overweight -> Overweight
2024-03-07HC Wainwright & Co.Reiterate Buy -> Buy
2023-11-13JP MorganMaintains Overweight -> Overweight
2023-10-18WedbushReiterate Outperform -> Outperform
2023-08-09HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 10, 2025
Period
Q3 / 2025
EPS Estimate
-$1.18
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-12.10%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-6.61%
EPS (3 Months)
-10.11%

Next Earnings Summary

ITOS is expected to report earnings on 11/10/2025. The consensus EPS estimate for the next earnings is -1.18 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ITOS revenue by date.ITOS revenue by date.
267.6M
-22.39%
12.595M
-95.29%
35M
177.89%

-100.00%
6.884M
-100.00%
3.337M357K
-89.30%
6.324M
1,671.43%
EBITDA
YoY % growth
ITOS ebitda by date.ITOS ebitda by date.
127.1M
-48.23%
-150.203M
-218.18%
-158.29M
-5.38%
-125.46M
20.74%
-95.88M
23.58%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ITOS ebit by date.ITOS ebit by date.
126.3M
-48.43%
-151.101M
-219.64%
-159.528M
-5.58%
-179.905M
-12.77%
-104.5M
41.91%
-169.098M
-61.82%
-164.64M
2.64%
-167.405M
-1.68%
-170.272M
-1.71%
-92.099M
45.91%
-97.569M
-5.94%
Operating Margin
ITOS operating margin by date.ITOS operating margin by date.
47.20%-1,199.69%-455.79%N/A-1,518.01%N/AN/AN/A-5,102.54%-25,798.00%-1,542.84%
EPS
YoY % growth
ITOS eps by date.ITOS eps by date.
N/A
-50.69%
-3.15
-213.87%
-3.33
-5.71%
-3.58
-7.51%
-2.08
41.81%
-1.84
11.75%
-2.72
-48.13%
-2.73
-0.37%
-2.76
-0.93%
-2.33
15.71%
-2.23
3.95%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.18
-12.10%
-0.43
58.74%
-0.49
38.16%
-0.54
62.02%
-0.56
52.56%
-0.51
-20.00%
-0.05
89.69%
-0.05
90.42%
-0.05
90.32%
-0.06
89.00%
Revenue
Q2Q % growth
N/AN/A4.709MN/A
EBITDA
Q2Q % growth
-22.44M
53.13%
-22.44M
53.34%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-54.746M
-12.19%
-25.24M
48.84%
-17.724M
63.40%
-18.354M
72.79%
-18.482M
66.24%
-19.127M
24.22%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ITOS Yearly Revenue VS EstimatesITOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2026 2030 2031 2032 100M 200M 300M
ITOS Yearly EPS VS EstimatesITOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.13%
EPS Next 5 Year
3.35%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

ITEOS THERAPEUTICS INC / ITOS Forecast FAQ

What is the price target for ITOS stock?

10 analysts have analysed ITOS and the average price target is 10.56 USD. This implies a price increase of 4% is expected in the next year compared to the current price of 10.15.

What is the next earnings date for ITOS stock?

ITEOS THERAPEUTICS INC (ITOS) will report earnings on 2025-11-10, before the market open.

Can you provide the consensus estimates for ITEOS THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of ITEOS THERAPEUTICS INC (ITOS) is -1.18 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for ITEOS THERAPEUTICS INC stock?

The consensus rating for ITEOS THERAPEUTICS INC (ITOS) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.